首页> 美国卫生研究院文献>Particle and Fibre Toxicology >Differential bioreactivity of neutral cationic and anionic polystyrene nanoparticles with cells from the human alveolar compartment: robust response of alveolar type 1 epithelial cells
【2h】

Differential bioreactivity of neutral cationic and anionic polystyrene nanoparticles with cells from the human alveolar compartment: robust response of alveolar type 1 epithelial cells

机译:中性阳离子和阴离子聚苯乙烯纳米粒子与人肺泡腔室细胞的差异生物反应性:肺泡1型上皮细胞的强大反应

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundEngineered nanoparticles (NP) are being developed for inhaled drug delivery. This route is non-invasive and the major target; alveolar epithelium provides a large surface area for drug administration and absorption, without first pass metabolism. Understanding the interaction between NPs and target cells is crucial for safe and effective NP-based drug delivery. We explored the differential effect of neutral, cationic and anionic polystyrene latex NPs on the target cells of the human alveolus, using primary human alveolar macrophages (MAC) and primary human alveolar type 2 (AT2) epithelial cells and a unique human alveolar epithelial type I-like cell (TT1). We hypothesized that the bioreactivity of the NPs would relate to their surface chemistry, charge and size as well as the functional role of their interacting cells in vivo.
机译:背景技术正在研发工程化的纳米颗粒(NP),用于吸入药物输送。这条路线是非侵入性的,并且是主要目标。肺泡上皮为药物的给药和吸收提供了较大的表面积,而无需首过代谢。了解NP与靶细胞之间的相互作用对于安全有效地基于NP的药物递送至关重要。我们使用人类初级肺泡巨噬细胞(MAC)和人类初级肺泡2型(AT2)上皮细胞和独特的人类I型肺泡上皮细胞探索中性,阳离子和阴离子聚苯乙烯乳胶NPs对人类肺泡靶细胞的差异作用样细胞(TT1)。我们假设NP的生物反应性将与它们的表面化学,电荷和大小以及它们在体内相互作用的细胞的功能有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号